Eledon Pharmaceuticals Stock Analysis
| ELDN Stock | USD 4.78 0.04 0.84% |
Eledon Pharmaceuticals is undervalued with Real Value of 6.65 and Hype Value of 4.73. The main objective of Eledon Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Eledon Pharmaceuticals is worth, separate from its market price. There are two main types of Eledon Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Eledon Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Eledon Pharmaceuticals is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Eledon Stock trading window is adjusted to America/New York timezone.
Eledon |
Eledon Stock Analysis Notes
About 43.0% of the company shares are held by institutions such as insurance companies. The book value of Eledon Pharmaceuticals was currently reported as 1.85. The company has Price/Earnings To Growth (PEG) ratio of 0.01. Eledon Pharmaceuticals last dividend was issued on the 5th of October 2020. The entity had 1:18 split on the 5th of October 2020. Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis , and requiring an organ or cell-based transplant. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California. Eledon Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people. To learn more about Eledon Pharmaceuticals call the company at 949 238 8090 or check out https://eledon.com.Eledon Pharmaceuticals Investment Alerts
| Eledon Pharmaceuticals generated a negative expected return over the last 90 days | |
| Eledon Pharmaceuticals has high historical volatility and very poor performance | |
| Eledon Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (116.54 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Eledon Pharmaceuticals currently holds about 70.46 M in cash with (39.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.12, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Eledon Pharmaceuticals has a frail financial position based on the latest SEC disclosures |
Eledon Pharmaceuticals Upcoming and Recent Events
Earnings reports are used by Eledon Pharmaceuticals to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Eledon Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 283.16 M.Technical Drivers
As of the 30th of January, Eledon Pharmaceuticals shows the Variance of 21.37, mean deviation of 3.52, and Standard Deviation of 4.62. Eledon Pharmaceuticals technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Eledon Pharmaceuticals Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Eledon Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Eledon Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Eledon Pharmaceuticals Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Eledon Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Eledon Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Eledon Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Eledon Pharmaceuticals Outstanding Bonds
Eledon Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Eledon Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Eledon bonds can be classified according to their maturity, which is the date when Eledon Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| ELEMENT SOLUTIONS INC Corp BondUS28618MAA45 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Eledon Pharmaceuticals Predictive Daily Indicators
Eledon Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Eledon Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 13215.28 | |||
| Daily Balance Of Power | 0.1538 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 4.73 | |||
| Day Typical Price | 4.75 | |||
| Price Action Indicator | 0.07 | |||
| Period Momentum Indicator | 0.04 |
Eledon Pharmaceuticals Forecast Models
Eledon Pharmaceuticals' time-series forecasting models are one of many Eledon Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Eledon Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Eledon Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Eledon Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Eledon shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Eledon Pharmaceuticals. By using and applying Eledon Stock analysis, traders can create a robust methodology for identifying Eledon entry and exit points for their positions.
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis , and requiring an organ or cell-based transplant. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California. Eledon Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Eledon Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Price Exposure Probability Now
Price Exposure ProbabilityAnalyze equity upside and downside potential for a given time horizon across multiple markets |
| All Next | Launch Module |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eledon Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Eledon Stock, please use our How to Invest in Eledon Pharmaceuticals guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eledon Pharmaceuticals. If investors know Eledon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eledon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Eledon Pharmaceuticals is measured differently than its book value, which is the value of Eledon that is recorded on the company's balance sheet. Investors also form their own opinion of Eledon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eledon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eledon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eledon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eledon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eledon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eledon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.